Companies / South Africa
Price Cuts Not Benefiting Patients?
October 2006 | Industry NewsWhile medicines have fallen in South Africa since the government began direct regulation in 2002, savings are not being passed on to the consumer, claims Innovative Medicines SA (Imsa), which represents multinational drugmakers.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
